Health News Releases

  • Today November 13
November 12, 13:30
Abu Dhabi Future Health Summit Concludes with Research Partnerships and New Programmes to Advance Prevention and Health Innovation
Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, Abu Dhabi Future Health Summit 2026 c
November 11, 15:50
FDA Approves PIMJETMI® (pimicotinib) for Patients with Tenosynovial Giant Cell Tumor
Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has approved PIMJETMI® (pimicotinib), a once-daily oral colony stimulating factor-1 re
November 11, 11:40
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in MSI-High Solid Tumors
The U.S. Food and Drug Administration (FDA) has approved the Promega OncoMate® MSI Dx Analysis System designed to identify patients with microsatellite high (MSI-H) solid tumors as a companion diagnos
November 11, 10:30
Nominations Open for Sixth Edition of Aster Guardians Global Nursing Award 2027 Worth USD 250,000 Prize
Aster DM Healthcare has announced the launch of the sixth edition of the Aster Guardians Global Nursing Award, inviting registered nurses worldwide to showcase their contributions to healthcare and co
November 08, 14:00
Hyperice Unveils Normatec Elite Heat Legs: Integrated Heat Meets Dynamic Air Compression in a New Fully Wireless Design
Hyperice (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fhyperice.com%2F&esheet=54635621&newsitemid=20261105782891&lan=en-US&anchor=Hyperice&index=1&md5=34106d8e2449f6ac8c60e50255ca
November 08, 12:00
Angelalign Appoints Marco Gadola as Senior Advisor
Angelalign Technology Inc. (6699.HK) (“Angel”) http://www.angelaligner.com, a global clear aligner leader, today announced that Marco Gadola has joined Angel as Senior Advisor. In this role, Marco wil
November 08, 11:00
BeOne Medicines Announces Third Quarter 2026 Financial Results and Business Updates
BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbeonemedicines.com%2F&esheet=54635699&newsitemid=20261105790053&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md
November 08, 09:30
Shonan Beauty Clinic Named to Newsweek’s “World’s Best Hospitals & Clinics for Medical Tourism 2027”
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, tod
November 06, 14:20
U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma
BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and
November 06, 14:10
Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations
Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myel
November 06, 13:35
Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer
Trained Therapeutix Discovery (“TTxD”), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, annou
November 06, 11:55
GN Corporation’s academic event NCRM NICHE commemorates 21st anniversary of NCRM.
The XXI edition of Fujio Cup Quiz (FCQ) (https://www.fujiocupquiz.org/) in NCRM NICHE (https://www.ncrmniche.org/ncrmniche2026/agenda.html) 2026, hosted by GN Corporation (https://gncorporation.com/en
November 05, 17:25
MindWalk Announces Agreement with Teva Australia to Support Defined Antibody-Discovery Workflows
MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today announced a multi-year agreement with Teva Pharmaceuticals Australia Pty Ltd (“Teva Australia”) to deploy ReefIQ™, M
November 04, 14:00
Organigram to Acquire Aurora and Establish a Global Cannabis Leader
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (“Organigram”) and Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) (“Aurora”) today announced that they have entered into an arrangement agreement (the “A
November 04, 11:30
SuperElastic* Material Unveiled by Angelalign
Angelalign Technology Inc. (6699.HK) (“Angel”)http://www.angelaligner.com, a global clear aligner leader, today unveiled SuperElastic (MC-SE*), a new propietary aligner material that is a significant
November 04, 10:40
SBC Medical Forms Capital and Business Alliance with AtomicSoftware, Provider of the medicalforce Clinic Management Platform Used by 800+ Clinics in Japan
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, tod
November 03, 16:00
HistoSonics Receives Regulatory Approval in Singapore, Advancing Expansion Across Asia-Pacific
HistoSonics today announced that the company has received market authorization from Singapore’s Health Sciences Authority (HSA) for its Edison® Histotripsy System (under the device name HistoSonics Hi
November 03, 15:25
Agenus Announces Nature Medicine Publication of Multicenter UNICORN Phase 2 Trial Demonstrating Deep Responses with Neoadjuvant BOT+BAL in Resectable Colon Cancer
Agenus (https://www.agenusbio.com/) Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of results from the investigator-sponsored, multicenter P
November 03, 10:15
Galderma Announces Proposed Board Appointments and Chief Financial Officer Transition
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced proposed changes to its Board of Directors, aimed at further strengthening its governance and supporting its lo
November 02, 10:10
Parse Biosciences and Nomic Announce 100 Million Cell, Multimodal AI-ready Dataset for Immune Biology
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.parsebiosciences.com&esheet=54630656&newsitemid=20261029559438&lan=en-US&anchor=Parse+Biosciences&index=1&md5=9e
November 02, 09:40
LeBron James Deepens Commitment to WHOOP, Expanding 11-Year Relationship
WHOOP (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.whoop.com&esheet=54630732&newsitemid=20261029868502&lan=en-US&anchor=WHOOP&index=1&md5=8513403097c7e0799f673810576953ca), t
THE Korean Society of Ginseng holds the 14th International Symposium on Ginseng
October 30, 14:38
14th Ginseng Symposium Highlights Red Ginseng’s Multi-Targeted Benefits for Aging and Metabolic Health
Clinical and preclinical studies presented at the 14th International Symposium on Ginseng (https://www.ginsengsymposium.org/main.html), hosted by THE Korean Society of Ginseng (https://www.ginsengsoci
October 30, 10:40
Takeda Announces FY2026 First-Half Results Highlighting Launch Momentum and Pipeline Milestones
Takeda (TOKYO:4502/NYSE:TAK (https://www.takeda.com/investors/stock-information/)) announced financial results for the first half of fiscal year 2026 (April 1, 2026, to Sept. 30, 2026). The period inc
October 29, 11:40
IFF Identifies Ten Consumer Moments Reshaping Food and Beverage Innovation in the GLP-1 Era
IFF (https://www.iff.com/) (NYSE: IFF)—a global leader in flavors, fragrances and health and biosciences, today launched its latest report, “GLP-1 Consumer Moments of Opportunity.” The report uncovers
October 27, 10:50
WHOOP and Samuel Ross MBE Unveil Layer 2 of PROJECT TERRAIN
WHOOP (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.whoop.com%2Fie%2Fen%2F&esheet=54628071&newsitemid=20261026029587&lan=en-US&anchor=WHOOP&index=1&md5=bd05ef992e790810d4dc308
October 27, 10:08
Dong-A ST Highlights Preclinical Promise of Topical Icotrokinra for Psoriasis Treatment
Dong-A ST Co., Ltd. (https://www.donga-st.com/en/) (President and CEO Jae-hoon Jeong, KRX: 170900) announced that it presented preclinical research findings demonstrating the potential of a topical fo
David Weinreich, Global Head of R&D and Chief Medical Officer for the Healthcare business of Merck
October 27, 09:09
Two-Year Data of Pimicotinib Demonstrated Durable Tumor Control and Sustained Improvement in TGCT Symptoms and Joint Function
Merck, a leading science and technology company, today announced new two-year follow-up results from the Phase 3 MANEUVER study evaluating pimicotinib in patients with tenosynovial giant cell tumor (T
October 25, 15:25
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026
BeOne Medicines Ltd. (https://beonemedicines.com/)(Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines ac
October 25, 14:25
Mundipharma Announces Further Phase III ReSPECT Results Presented as a Late-Breaking Oral Presentation at IDWeek 2026
Today Mundipharma announced additional results from the global Phase III ReSPECT clinical trial evaluating REZZAYO® (rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult pat
October 25, 13:25
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis o
October 25, 13:05
Brenus Pharma’s Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.
Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS
October 25, 12:40
Takeda Announces Arcotatug Tavatecan (TAK-921) Demonstrated Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Phase 3 Advanced Gastric Cancer Study
Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) announced positive results from the Phase 3 G-HOPE-001 study (NCT06238843) of arcotatug tavatecan (TAK-921; Innovent R&D code: I
October 23, 15:40
SBC Medical Initiates Development of a DNA Methylation Test to Estimate Biological Age
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, tod
October 23, 15:22
Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines
Galderma (SIX: GALD) today announced that the Chinese NMPA has approved Relfydess for the temporary improvement of moderate-to-severe frown lines in adults, marking a significant expansion of the comp
October 23, 11:40
Future Health and Bridge for Billions to Launch Programme Strengthening Health Entrepreneurship in Emerging Markets
Future Health - A Global Initiative by Abu Dhabi and Bridge for Billions will launch a new entrepreneurship programme designed to strengthen promising health ventures in emerging markets and help loca
October 22, 14:48
Galderma Delivers Net Sales of 4.765 B USD in the First Nine Months, Up 25.1% at Constant Currency Year-on-Year, and Raises Full-Year Net Sales Guidance
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first nine months of 2026. · Record net sales of 4.765 billion USD for the fir
October 22, 10:00
MindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours
MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today published a white paper showing that its LensAI™ immunogenicity screening ran across an entire public antibody datab
October 22, 09:53
Merck Collaborates with NVIDIA, Microsoft and Dawn Health to Develop Novel Support Model for People Living with Rare Tumors
Merck, a leading science and technology company, today announced a collaboration with NVIDIA Corporation (Santa Clara, California, USA), Microsoft Corporation (Redmond, Washington, USA) and Dawn Healt
October 22, 09:40
Global Network for the Advancement of Metabolic Psychiatry (MetPsy) Launches with $20 Million Investment in Clinical Care, Education and Research at McLean Hospital
Baszucki Group today announced the launch of the Global Network for the Advancement of Metabolic Psychiatry (MetPsy (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fmetpsy.com%2Fannou
October 21, 17:30
Inaugural Future Health Impact Challenge Documentary Released as Expressions of Interest Open for Second Challenge
Future Health - A Global Initiative by Abu Dhabi today premiered a documentary film about the inaugural Future Health Impact Challenge during the first day of the Abu Dhabi Future Health Summit. The f
October 21, 15:53
AMWC Dubai 2026: Galderma Reinforces Its Injectable Aesthetics Leadership
Galderma (SIX: GALD) will showcase data from its leading innovative Injectable Aesthetics portfolio at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) taking place in Dubai, United Arab Emir
October 21, 13:55
Roquette Brings Broad Portfolio of Excipient Solutions and Technical Expertise to AAPS PharmSci 360 2026
Roquette, a global leader in plant-based ingredients, excipients and pharmaceutical solutions, will showcase its expansive portfolio of excipients, capsules, coatings, and biopharma solutions at AAPS
October 21, 09:50
Parse Biosciences Launches Evercode MAX, Enabling Researchers to Profile More Cells and Samples with Greater Flexibility
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fparsebiosciences.com&esheet=54624785&newsitemid=20261020402612&lan=en-US&anchor=Parse+Biosciences&index=1&md5=365fc2
October 20, 16:47
Hologic Signs Definitive Agreement to Acquire Reveal Genomics
Hologic, a global leader in women’s health, today announced that it has signed a definitive agreement to acquire Reveal Genomics, a precision oncology company based in Barcelona, Spain, that develops
October 20, 16:40
BeOne Medicines Highlights Rapidly Accelerating Solid Tumor Franchise at ESMO 2026
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that data from across its rapidly progressing solid tumor portfolio will be presented at the Eu
October 20, 14:40
Sultan bin Ahmed Launches 60-Home Village Project, Inaugurates Orphanage and Clinic in Southern Philippines
A 60-home village planned for Dinas on the southern Philippine island of Mindanao will provide housing, clean water and vocational training under a humanitarian programme supported by organisations ba
October 20, 09:50
First and Only Ulcerative Colitis Treat-to-Target Trial Shows Treating to Disease Clearance vs. Symptomatic Remission with ENTYVIO® (vedolizumab) Prolongs Time to First Disease-Related Complication
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54623752&newsitemid=20261019826127&lan=en-US&anchor=TSE%3A4
October 18, 11:05
Future Health Launches Global Challenge to Move Health Innovation Towards Real-world Application
Future Health - A Global Initiative by Abu Dhabi opened applications for the Future Health Digital Innovation Challenge 2026, welcoming innovators from around the world to develop AI, software, and co
October 16, 14:30
Takeda Presents Phase 2/3 IgGNITE Study Results of Investigational Subcutaneous TAK-881 in Primary Immunodeficiency Disease (PID) at ESID 2026
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54621245&newsitemid=20261014178348&lan=en-US&anchor=TSE%3A4
October 16, 12:00
New Study Brings Ketogenic Therapy for Bipolar Disorder Directly to Rural Alabama Homes
Baszucki Group today announced funding for a clinical study to examine the impact of ketogenic therapy on people living with bipolar disorder in rural Central Alabama. This study, led by researchers a
October 15, 15:30
MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies
MindWalk Holdings Corp. (NASDAQ: HYFT) (“MindWalk” or the “Company”), a Bio-Native AI company, today announced three senior appointments that strengthen its Boston-based development leadership as the
October 15, 14:35
PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new phase II data showing that nemolizumab provided meaningful improvements in itch, sleep disturbance, and quality of
October 15, 09:49
Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 1
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54622338&newsitemid=20261014922379&lan=en-US&anchor=TSE%3A4
October 14, 17:18
Galderma Signs Agreement to Acquire ZO Skin Health, Strengthening Its Physician-Dispensed Skincare Offering
Galderma (SIX: GALD) today announced that it has signed an agreement to acquire ZO® Skin Health, a leading physician-dispensed skincare brand built on clinical science and protocol-based daily care, f
AesMed Hair Care Day Campaign 2026
October 14, 09:00
AesMed Expands 1111 Hair Care Day Campaign 2026 to Support Hair Loss Patients and Promote Global Awareness
AesMed Co., Ltd. (https://www.aesmed.co.kr/main), a company specializing in science-based hair loss care solutions in Korea, announced it will continue the 1111 Hair Care Day Campaign 2026 (https://ww
October 13, 14:37
New Galderma Research Reveals More Than Half of Women Mistake Menopause-Related Skin Changes for Signs of Ageing
Galderma (SIX: GALD) today announced new global research revealing that more than half (56%) of women first put menopause-related skin changes down to general ageing, while only less than a third of w
October 13, 10:30
Doctors, Public Health Experts and Dental Leaders Call for Oral Health to Become Part of Everyday Health Care
Doctors, public-health experts and dental leaders are calling for oral health to be treated as part of overall health. Their message is clear: healthier teeth and gums matter beyond the mouth, and eff
October 12, 17:20
Armenia Grants First Marketing Authorizations for Agenus’ BOT+BAL in Previously Treated MSS Metastatic Colorectal Cancer
Agenus Inc. (https://www.agenusbio.com/) (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced that the Ministry of Health of the Republic of Armenia has granted marketing authorizat
October 08, 16:00
ClaroNav Kolahi Inc. Announces EU MDR Certification for Navient Surgical Navigation System
ClaroNav Kolahi Inc. (CKI), a global developer and manufacturer of surgical navigation technologies, today announced that its Navient Surgical Navigation System has received certification under the Eu
October 08, 14:34
Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio® Data Showing Deep and Lasting Skin Lesion and Itch Responses in Patients With Atopic Dermatitis Aged 12 and Older
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new data regarding the use of Nemluvio for atopic dermatitis and prurigo nodularis to be presented at the 2026 Fall Cli
October 08, 14:15
Medisca and EUROAPI Form Strategic Partnership to Strengthen API Access for Pharmaceutical Compounding
Medisca and EUROAPI have formed a strategic partnership focused on expanding API access for pharmaceutical compounding, creating differentiated access in North America and establishing a broader frame
October 08, 11:40
Rivercell Launches With $25 Million to Build Data Platforms and AI Models That Predict How Human Cells Respond to Treatment
Rivercell, a Paris-based biotechnology and AI company building its own data infrastructure on how human cells respond to any treatment and training a world model of the cell that can predict those res
October 07, 17:00
MindWalk (NASDAQ: HYFT): Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological Function
MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today outlined why the ontology layer now being built across enterprise AI does not reach biological function, and why lif
October 07, 11:20
Invivoscribe® Advances Molecular Clonality Testing Portfolio with Comprehensive LymphoTrack® Flex Suite
Invivoscribe, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced the launch of the complete LymphoTrack Flex suite, an integrated next-generation s
October 06, 16:10
30 Years of Restylane®: Reshaping the Aesthetics Field Through Science-Led, Patient-Centric Innovation
Galderma (SIX: GALD), the pure-play dermatology category leader, celebrates 30 years since Restylane was launched in Europe as the first hyaluronic acid (HA) injectable.[1] With HA closest to the skin
SOFIE Biosciences has 15 CMO sites across the U.S., manufacturing PET radiopharmaceutical products
October 06, 09:33
GE HealthCare to Acquire SOFIE Biosciences, Establishing a ‘Final Mile’ Footprint for PET Radiopharmaceutical Supply in the U.S.
GE HealthCare (Nasdaq: GEHC) today announced a definitive agreement to acquire SOFIE Biosciences, a leading U.S.-based CMO for PET radiopharmaceuticals, from Trilantic North America, for a purchase pr
October 05, 15:35
Agenus Reports 48% Estimated Three-Year Survival With BOT+BAL in Recurrent Ovarian Cancer at IGCS 2026
Agenus Inc. (https://www.agenusbio.com/) (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced three-year follow-up results from the ovarian cancer cohort of its 400+ patient Phase 1
October 05, 14:50
LISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion
Nearly half the world’s population is affected by oral disease - and the number of cases is rising. This World Smile Day, LISTERINE® is launching Oral Care Counts - a multiyear education and advocacy
October 05, 12:10
Global Health Leaders to Convene at Abu Dhabi Future Health Summit 2026
Global leaders across healthcare, science, technology, policy, and investment will convene at the Abu Dhabi Future Health Summit from 20 to 22 October 2026 to examine how health systems can better ant
October 05, 11:30
Roquette to Showcase End-to-End Pharma Solutions for Patient-Centric Formulations at CPHI Milan 2026
Roquette will showcase its end-to-end portfolio of pharmaceutical excipients, drug delivery solutions and leading technical expertise at CPHI Milan 2026 in Italy, where the company will welcome visito
October 02, 11:50
Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair
Neutrogena®, Aveeno®, and Regaine®* will present 12 new scientific data sets at the 35th European Academy of Dermatology and Venereology (EADV) Congress taking place September 30th through October 3rd
October 02, 09:54
Samsung Bioepis and Teva Expand Strategic Partnership to Advance Up to Six Potential Biosimilar Candidates
Samsung Bioepis Co., Ltd. and Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the companies have entered into a global license, development, and commercialization agreem
Personalized hair loss treatments and scalp care are provided (Image: HairON Clinic)
October 01, 16:50
HairON Develops ‘FolliOn Injection’ Focused on Restoring Hair Follicle Function
HairON (https://haironclinic.com/en/), a brand specializing in scalp and hair loss care, has unveiled the brand story behind its newly developed ‘FolliOn Injection,’ which focuses on restoring hair fo
October 01, 16:00
Promega Launches Paradyme™ 27GY STR System, Minimizing Stutter Artifacts in Forensic DNA Analysis
Promega Corporation has launched Paradyme™ 27GY STR System, the first commercially available short tandem repeat (STR) analysis kit to include the company’s Reduced-Stutter Polymerase (RSP). This nove
Personalized hair loss treatments and scalp care are provided (Image: HairON Clinic)
October 01, 15:47
HairON Clinic Completes Trademark Registration for ‘FolliOn,’ a Hair Loss Treatment Combining PDRN, Growth Factors and Spicules
HairON Clinic (https://haironclinic.com/en/), which specializes in hair loss treatment, announced that it has completed the trademark registration for ‘FolliOn,’ a next-generation hair loss treatment
September 30, 17:31
EADV 2026: Galderma’s New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis
Galderma (SIX: GALD), the pure-play dermatology category leader, is presenting new three-year data from the ARCADIA long-term extension study, demonstrating that Nemluvio is well-tolerated and associa
September 30, 10:30
KARA Clinical Ambassador Network Tops 800 Members in Korea and Expands to Latin America
KARA Clinical Global (https://karaclinical.com/en), the Seoul-based at-home skincare technology company, today announced that the KARA Clinical Ambassador Network (KCAN) has grown to more than 800 amb
September 27, 15:40
Future Health Convenes Global Health Leaders at UNGA to Advance Health System Transformation at Scale
Future Health - A Global Initiative by Abu Dhabi convened Ministers, senior government representatives, and global health leaders in New York on the sidelines of the 81st Session of the United Nations
September 26, 15:55
Novotech to acquire Agilex Biolabs
Novotech, the global full-service clinical research organisation (CRO) and scientific advisory company, today announced it has reached agreement with a wholly owned subsidiary of leading Australian he
September 26, 14:30
The Estée Lauder Companies and the Breast Cancer Research Foundation Launch Largest Global Research Initiative on Breast Cancer in Younger Women
The Estée Lauder Companies today announced a new five-year commitment to the Breast Cancer Research Foundation to establish the Global Research Initiative on Breast Cancer in Younger Women. This first
September 26, 11:45
Future Health - A Global Initiative by Abu Dhabi: New Analysis Estimates Modifiable Health Risks Represent $16.4 Trillion Annual Global GDP Opportunity in 2050
Addressing behavioural, metabolic and environmental health risks could generate an estimated $16.4 trillion in annual global GDP uplift in 2050. These findings are presented in The Future of Healthy L
September 26, 10:57
Acadia Pharmaceuticals Announces Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis (ADP)
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced Phase 3 enabling topline results from the Phase 2 portion of the ongoing RADIANT clinical trial program evaluating remlifanserin for the trea
September 26, 09:55
Copeland Completes Acquisition of Dickson, Advancing Cold Chain Intelligence for Healthcare and Life Sciences
Copeland, a global leader in compression technologies and controls solutions, today announced it has completed the acquisition of Dickson, a Chicago-based provider of environmental monitoring and comp
September 23, 17:13
Takeda Highlights Late-Stage Oncology Pipeline Progress and Solid Tumor Portfolio Research, Led by Late-Breaking Phase 3 Arcotatug Tavatecan (TAK-921) Data, at ESMO 2026
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54608238&newsitemid=20260921356638&lan=en-US&anchor=TSE%3A4
September 23, 17:00
From CSR to Public Health Impact: How Colgate Bright Smiles, Bright Futures® is Driving Behavior Change for the Next Billion Children and Their Families
Colgate-Palmolive, the worldwide leader in oral care, announced a strategic evolution in its flagship oral health education program, Colgate Bright Smiles, Bright Futures® (BSBF), reflecting the Compa
September 23, 16:45
EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences
Galderma (SIX: GALD), the pure-play dermatology category leader, will present 19 abstracts and deliver a broad scientific education program at the 2026 European Academy of Dermatology and Venereology
ICL, Cataract Surgery, and Smile LASIK are being performed (Image: Onnuri Smile Eye Clinic)
September 23, 10:56
Onnuri Smile Eye Clinic’s 1mm SMILE Pro Technique Draws Attention for Surgical Safety and Recovery
Onnuri Smile Eye Clinic (https://www.onnurismile.com/), an ophthalmology clinic in South Korea, announced that its proprietary, patented 1mm ultra-small-incision SMILE Pro technique is drawing great a
September 21, 15:19
Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies
Galderma (SIX: GALD), the pure-play dermatology category leader, today begins trading as a constituent of the Swiss Market Index (SMI), Switzerland‘s leading blue chip equity benchmark comprising 20 o
September 18, 17:47
Takeda Employees Select Four New Global Corporate Social Responsibility Collaborations to Advance Climate-Resilient Health Systems
Takeda (TSE:4502/NYSE: TAK) announced that it has awarded a total of USD 22.2 million to four new Global Corporate Social Responsibility (CSR) partners as part of the company’s ongoing commitment to s
September 18, 16:00
Medisca Launches Global Peptide Division
Medisca today announced the launch of Medisca Peptides, a dedicated global division focused on expanding access to API-grade peptides and building an integrated peptide platform for pharmaceutical and
September 18, 15:20
AMRA Medical Earns TIME’s Highest “Outstanding” Rating in World’s Top HealthTech Companies 2026
The 2026 result builds on AMRA’s inclusion in the inaugural ranking in 2025, when the company received a “Very High” designation. Its advancement to the top category reflects continued progress in sci
September 17, 15:15
Rubedo Life Sciences Announces Clinical Study to Treat Hair Loss with GPX4 Modulator RLS-1496, First Human Ex Vivo Evidence Demonstrates Robust Hair Follicle Growth
Rubedo Life Sciences, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fprotect.checkpoint.com%2Fv2%2Fr01%2F___https%3A%2Fwww.rubedolife.com%2F___.YzJ1OmdpbG1hcnRpbmdyb3VwOmM6b2Z
September 17, 10:28
Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing
Galderma (SIX: GALD) today announced positive topline results from a study of Restylane Volyme for the correction of moderate-to-severe temple hollowing in 162 patients in China.[1] The study met its
September 16, 16:35
QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases
QurCan Therapeutics (“QurCan”), a biotechnology company pioneering non-viral, polymer-lipid nanoparticle (PLNP) delivery of genetic medicines through its proprietary TERP™ (Target-Engineered Responsiv
September 16, 08:37
Chiesi Appoints David Khougazian as Group Chief Executive Officer to Lead the Next Phase of Innovation-Driven Growth
Chiesi Group (Chiesi) today announced the appointment of David Khougazian as Group Chief Executive Officer (CEO), effective 15 October 2026. David joins Chiesi following a distinguished internation
September 15, 10:15
Fujirebio Expands Access to Blood-based Neurology Testing in Brazil with ANVISA Market Authorization for Lumipulse® G NfL Blood and Lumipulse G pTau 217 Plasma
H.U. Group Holdings Inc. and its wholly owned subsidiary Fujirebio today announced that the Brazilian Health Regulatory Agency (ANVISA) has granted market authorization for the Lumipulse G NfL Blood a
September 15, 09:50
Aster Guardians Global Nursing Award 2026 Names Agimol Pradeep From United Kingdom Winner of USD 250,000 Prize
From more than 134,000 registrations spanning 214 countries and economies, Nurse Agimol Pradeep from United Kingdom has been announced as the winner of the Aster Guardians Global Nursing Award 2026. A
September 14, 17:23
U.S. FDA Accepts New Drug Application Under Priority Review for Takeda’s Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral Treatment Expectations
Takeda (TSE:4502/NYSE:TAK (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2Finvestors%2Foverview%2F&esheet=54602408&newsitemid=20260914748441&lan=en-US&anchor=TSE%3A4
September 11, 13:30
Three Chugai Researchers Behind the Discovery of Hemlibra for Hemophilia A Receive Prestigious U.S. Lasker Award, One of the World’s Most Respected Scientific Honors
Chugai Pharmaceutical Co., Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.chugai-pharm.co.jp%2Fenglish%2Findex.html&esheet=54600887&newsitemid=20260909923883&lan=en-US&anc
September 10, 15:25
New England Journal of Medicine Publishes Data from Phase 3 Studies Demonstrating Oveporexton (ORZEYFUL) Improved the Full Range of Narcolepsy Type 1 Symptoms and Quality of Life
Takeda (TSE:4502/NYSE:TAK) announced that the New England Journal of Medicine (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.nejm.org%2Fstoken%2Fdefault%2Bdomain%2FREPRINTS_375
25 per page50 per page75 per page100 per page